Moreover, elevated Lp(a) levels have been linked not only to an increased risk of developing CAVD but also to faster disease progression, an earlier need for aortic valve replacement, and higher mortality rates [138,139]. This evidence concerns the gene LPA and congenital bilateral aplasia of vas deferens from CFTR mutation.